Endoglin (ENG) Peptide
ENG
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
-
- Target See all Endoglin (ENG) products
- Endoglin (ENG)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- ILEVHVLFLE FPTGPSQLEL TLQASKQNGT WPREVLLVLS VNSSVFLHLQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ENG antibody,
Alternative Names: Endoglin control peptide, Endoglin antibody Blocking Peptide, Anti-Endoglin Blocking Peptide, Osler-Rendu-Weber Syndrome 1 Blocking Peptide, ENG Blocking Peptide - Purification
- Unpurified neat serum.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Endoglin (ENG)
- Background
- Endoglin is a homodimeric transmembrane glycoprotein highly expressed by endothelial cells. It is a component of the transforming growth factor beta receptor complex since it binds TGFB1 and TGFB3 with high affinity. Mutations in the endoglin gene produce hereditary hemorrhagic telangiectasia.
- Molecular Weight
- 68 kDa
-
You are here:
